LivaNova (NASDAQ:LIVN) Rating Lowered to Buy at Wall Street Zen

LivaNova (NASDAQ:LIVN) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday.

Several other research analysts have also weighed in on LIVN. Barclays upped their target price on LivaNova from $55.00 to $58.00 and gave the stock an “equal weight” rating in a research report on Thursday, August 21st. Needham & Company LLC reissued a “buy” rating and set a $64.00 target price on shares of LivaNova in a research report on Wednesday, September 3rd. Mizuho boosted their price target on LivaNova from $65.00 to $70.00 and gave the stock an “outperform” rating in a research report on Thursday, November 13th. The Goldman Sachs Group set a $55.00 price target on LivaNova and gave the stock a “neutral” rating in a research note on Wednesday, October 1st. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of LivaNova in a research note on Monday, December 1st. Five investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $62.43.

LivaNova Trading Down 0.8%

NASDAQ:LIVN opened at $63.36 on Friday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.33 and a quick ratio of 1.12. The stock has a market cap of $3.46 billion, a PE ratio of -15.84 and a beta of 1.02. The stock’s 50-day moving average is $55.14 and its two-hundred day moving average is $50.93. LivaNova has a fifty-two week low of $32.48 and a fifty-two week high of $64.45.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of LIVN. Artisan Partners Limited Partnership boosted its stake in LivaNova by 94.5% in the 3rd quarter. Artisan Partners Limited Partnership now owns 2,427,045 shares of the company’s stock valued at $127,129,000 after buying an additional 1,179,436 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of LivaNova by 83.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,345,516 shares of the company’s stock valued at $122,858,000 after purchasing an additional 1,067,349 shares in the last quarter. Invesco Ltd. grew its holdings in shares of LivaNova by 714.7% in the 2nd quarter. Invesco Ltd. now owns 1,028,713 shares of the company’s stock worth $46,313,000 after purchasing an additional 902,447 shares during the last quarter. AQR Capital Management LLC increased its position in shares of LivaNova by 111.7% during the 1st quarter. AQR Capital Management LLC now owns 1,571,295 shares of the company’s stock worth $60,809,000 after purchasing an additional 829,115 shares in the last quarter. Finally, Scopia Capital Management LP bought a new position in LivaNova during the 2nd quarter valued at about $36,657,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.